Efficacy of a Combined Strategy to Improve Low-density Lipoprotein Cholesterol Control Among Patients With Hypercholesterolemia: A Randomized Clinical Trial

Cholesterol Control ◽

Combined Strategy

Author Correction: Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial

Scientific Reports ◽

10.1038/s41598-020-60644-9 ◽

2020 ◽

Vol 10 (1) ◽

Author(s):

Takeshi Morimoto ◽

Ichiro Sakuma ◽

Mio Sakuma ◽

Akihiro Tokushige ◽

Masahiro Natsuaki ◽

...

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Open Label ◽

Randomized Evaluation

Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial

Scientific Reports ◽

10.1038/s41598-019-44885-x ◽

2019 ◽

Vol 9 (1) ◽

Cited By ~ 5

Author(s):

Takeshi Morimoto ◽

Ichiro Sakuma ◽

Mio Sakuma ◽

Akihiro Tokushige ◽

Masahiro Natsuaki ◽

...

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Open Label ◽

Randomized Evaluation

Contribution of High Plasma Triglycerides and Low High-Density Lipoprotein Cholesterol to Residual Risk of Coronary Heart Disease After Establishment of Low-Density Lipoprotein Cholesterol Control

The American Journal of Cardiology ◽

10.1016/j.amjcard.2010.05.002 ◽

2010 ◽

Vol 106 (6) ◽

pp. 757-763 ◽

Cited By ~ 91

Author(s):

Vincent J. Carey ◽

Louise Bishop ◽

Nancy Laranjo ◽

Benjamin J. Harshfield ◽

Carolyn Kwiat ◽

...

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

High Plasma ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Plasma Triglycerides ◽

A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d

Clinical Therapeutics ◽

10.1016/s0149-2918(03)80330-2 ◽

2003 ◽

Vol 25 (11) ◽

pp. 2738-2753 ◽

Cited By ~ 12

Author(s):

Michael H. Davidson ◽

Joanne Palmisano ◽

Helene Wilson ◽

Charles Liss ◽

Mary R. Dicklin

Keyword(s):

Clinical Trial ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Double Blind ◽

Cholesterol Lowering ◽

Double Blind Clinical Trial

Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients

European Journal of Preventive Cardiology ◽

10.1177/2047487317693134 ◽

2017 ◽

Vol 24 (9) ◽

pp. 981-989 ◽

Cited By ~ 24

Author(s):

John Munkhaugen ◽

Elise Sverre ◽

Jan E Otterstad ◽

Kari Peersen ◽

Erik Gjertsen ◽

...

Keyword(s):

Psychosocial Factors ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Coronary Patients ◽

Trends in high-intensity statin use and low-density lipoprotein cholesterol control among patients enrolled in a clinical pharmacy cardiac risk service

Journal of Clinical Lipidology ◽

10.1016/j.jacl.2018.04.007 ◽

2018 ◽

Vol 12 (4) ◽

pp. 999-1007

Author(s):

Donald G. Lamprecht ◽

Paul B. Shaw ◽

Jordan B. King ◽

Keri N. Hogan ◽

Kari L. Olson

Keyword(s):

Clinical Pharmacy ◽

High Intensity ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Cardiac Risk ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Cholesterol Control ◽

Statin Use

Situational Analysis of Low-density Lipoprotein Cholesterol Control and the Use of Statin Therapy in Diabetes Patients Treated in Community Hospitals in Nanjing, China

Chinese Medical Journal ◽

10.4103/0366-6999.223857 ◽

2018 ◽

Vol 131 (3) ◽

pp. 295-300 ◽

Cited By ~ 3

Author(s):

Xiao-Jun Ouyang ◽

Yong-Qing Zhang ◽

Ji-Hai Chen ◽

Ting Li ◽

Tian-Tian Lu ◽

...

Keyword(s):

Statin Therapy ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Situational Analysis ◽

Low Density ◽

Community Hospitals ◽

Cholesterol Control ◽

Diabetes Patients

Prevalence of the Metabolic Syndrome in Patients With Hypertension Treated in General Practice in Spain: An Assessment of Blood Pressure and Low-Density Lipoprotein Cholesterol Control and Accuracy of Diagnosis

Journal of the CardioMetabolic Syndrome ◽

10.1111/j.1559-4564.2007.06313.x ◽

2007 ◽

Vol 2 (1) ◽

pp. 9-15 ◽

Cited By ~ 20

Author(s):

Vivencio Barrios ◽

Carlos Escobar ◽

Alberto Calderón ◽

José L. Llisterri ◽

Eduardo Alegría ◽

...

Keyword(s):

Blood Pressure ◽

Metabolic Syndrome ◽

General Practice ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

The Metabolic Syndrome ◽

EVALUATING BENCHMARKING TO OPTIMIZE MANAGEMENT OF TYPE 2 DIABETIC PATIENTS: LOW-DENSITY LIPOPROTEIN CHOLESTEROL CONTROL IN THE EUROPEAN OPTIMISE STUDY

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(11)61195-9 ◽

2011 ◽

Vol 57 (14) ◽

pp. E1195

Author(s):

Ryan Franca ◽

Michel Hermans ◽

Erik Muls ◽

Carlos Brotons ◽

Moses Elisaf ◽

...

Keyword(s):

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Diabetic Patients ◽

Low Density ◽

Type 2 Diabetic Patients ◽

Cholesterol Control ◽

Type 2 Diabetic

P631Sex-related differences in clinical characteristics, low-density lipoprotein cholesterol control and cardiovascular outcomes in familial hypercholesterolemia

European Heart Journal ◽

10.1093/eurheartj/ehx501.p631 ◽

2017 ◽

Vol 38 (suppl_1) ◽

Cited By ~ 1

Author(s):

T. Doi ◽

Y. Kataoka ◽

Y. Asaumi ◽

M. Hori ◽

R. Nishikawa ◽

...

Keyword(s):

Familial Hypercholesterolemia ◽

Clinical Characteristics ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Cardiovascular Outcomes ◽

Lipoprotein Cholesterol ◽

Low Density ◽